2-(4-Bromo-1H-pyrazol-1-yl)pyrimidine

Catalog No. :
ACDWGK671
CAS No. :
857641-46-4
Molecular Formula :
C7H5BrN4
Molecular Weight :
225.05

IUPAC Name:2-(4-bromo-1H-pyrazol-1-yl)pyrimidine

2-(4-Bromo-1H-pyrazol-1-yl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$146.00Login to see priceInquiryInquiry
1g96%$339.00Login to see priceInquiryInquiry
5g96%$938.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Bromo-1H-pyrazol-1-yl)pyrimidine
IUPAC Name2-(4-bromo-1H-pyrazol-1-yl)pyrimidine
MDL No.MFCD09834926
Molecular FormulaC7H5BrN4
Molecular Weight225.05
SMILESBrC1=C[N](N=C1)C2=NC=CC=N2
InChI KeyOLHCXNGGKICQLL-UHFFFAOYSA-N
Synonym2-(4-BROMO-PYRAZOL-1-YL)-PYRIMIDINE | 2-(4-bromopyrazol-1-yl)pyrimidine | SCHEMBL1198582 | Pyrimidine,2-(4-bromo-1H-pyrazol-1-yl)- | OLHCXNGGKICQLL-UHFFFAOYSA-N | 2-(4-Bromo-1H-pyrazol-1-yl)pyrimidine | DTXSID00671956 | MFCD09834926 | AKOS010257613 | AB52
CAS No.857641-46-4
PubChem CID45789701

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACDWGK671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDWGK671 route product structure diagram
    ACDWGK671857641-46-4
Inquiry

2. ACDWGK671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACDWGK671 route product structure diagram
    ACDWGK671857641-46-4
Inquiry

Comments (0)